166 related articles for article (PubMed ID: 37102193)
1. Racial/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds.
Kitsantas P; Aljoudi SM; Baker KM; Peppard L; Oh KM
J Subst Use Addict Treat; 2023 May; 148():208960. PubMed ID: 37102193
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
[TBL] [Abstract][Full Text] [Related]
3. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
Xu KY; Schiff DM; Jones HE; Martin CE; Kelly JC; Bierut LJ; Carter EB; Grucza RA
J Gen Intern Med; 2023 Dec; 38(16):3499-3508. PubMed ID: 37436568
[TBL] [Abstract][Full Text] [Related]
5. Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy.
Gao YA; Drake C; Krans EE; Chen Q; Jarlenski MP
J Addict Med; 2022 Nov-Dec 01; 16(6):e356-e365. PubMed ID: 35245918
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Differences in Receipt of Nonpharmacologic Care for Chronic Low Back Pain Among Medicare Beneficiaries With OUD.
Bhondoekhan F; Marshall BDL; Shireman TI; Trivedi AN; Merlin JS; Moyo P
JAMA Netw Open; 2023 Sep; 6(9):e2333251. PubMed ID: 37698860
[TBL] [Abstract][Full Text] [Related]
7. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
Pro G; Utter J; Haberstroh S; Baldwin JA
Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
[TBL] [Abstract][Full Text] [Related]
8. Disparities in receipt of medications for opioid use disorder among pregnant women.
Henkhaus LE; Buntin MB; Henderson SC; Lai P; Patrick SW
Subst Abus; 2022; 43(1):508-513. PubMed ID: 34270396
[No Abstract] [Full Text] [Related]
9. Duration of medication for opioid use disorder during pregnancy and postpartum by race/ethnicity: Results from 6 state Medicaid programs.
Austin AE; Durrance CP; Ahrens KA; Chen Q; Hammerslag L; McDuffie MJ; Talbert J; Lanier P; Donohue JM; Jarlenski M
Drug Alcohol Depend; 2023 Jun; 247():109868. PubMed ID: 37058829
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment.
Chang JE; Franz B; Cronin CE; Lindenfeld Z; Lai AY; Pagán JA
J Subst Abuse Treat; 2022 Jul; 138():108719. PubMed ID: 35125254
[TBL] [Abstract][Full Text] [Related]
11. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
[TBL] [Abstract][Full Text] [Related]
12. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care.
Faiz J; Bernstein E; Dugas JN; Schechter-Perkins EM; Nentwich L; Nelson KP; Cleveland Manchanda EC; Young L; Pare JR
Am J Emerg Med; 2022 Apr; 54():221-227. PubMed ID: 35180668
[TBL] [Abstract][Full Text] [Related]
13. Race and ethnicity are among the predisposing factors for fetal malpresentation at term.
Bar-El L; Eliner Y; Grunebaum A; Lenchner E; Wasden SW; Chervenak FA; Bornstein E
Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100405. PubMed ID: 34091061
[TBL] [Abstract][Full Text] [Related]
14. Maternal Birthplace is Associated with Low Birth Weight Within Racial/Ethnic Groups.
Wartko PD; Wong EY; Enquobahrie DA
Matern Child Health J; 2017 Jun; 21(6):1358-1366. PubMed ID: 28093687
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).
Peeler M; Gupta M; Melvin P; Bryant AS; Diop H; Iverson R; Callaghan K; Wachman EM; Singh R; Houghton M; Greenfield SF; Schiff DM
Am J Public Health; 2020 Dec; 110(12):1828-1836. PubMed ID: 33058701
[No Abstract] [Full Text] [Related]
16. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.
Short VL; Hand DJ; MacAfee L; Abatemarco DJ; Terplan M
J Subst Abuse Treat; 2018 Jun; 89():67-74. PubMed ID: 29706175
[TBL] [Abstract][Full Text] [Related]
17. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.
Miles J; Treitler P; Hermida R; Nyaku AN; Simon K; Gupta S; Crystal S; Samples H
Drug Alcohol Depend; 2023 Nov; 252():110963. PubMed ID: 37748421
[TBL] [Abstract][Full Text] [Related]
19. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States.
Sanmartin MX; McKenna RM; Ali MM; Krebs JD
J Ment Health Policy Econ; 2020 Mar; 23(1):19-25. PubMed ID: 32458814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]